Surgical treatment of congenital valvular aortic stenosis

Thorax
|August 1, 1976
PubMed

Insights

Surgical aortic valvotomy for congenital aortic stenosis offers palliative relief in infants but carries high risks. Older patients experience more favorable outcomes with this procedure.

Area of Science:

  • Cardiology
  • Pediatric Surgery
  • Cardiac Surgery

Background:

  • Congenital valvular aortic stenosis presents a significant challenge in pediatric cardiac care.
  • The condition can lead to severe heart failure and left ventricular hypertrophy, particularly in infants.

Purpose of the Study:

  • To evaluate the surgical outcomes of aortic valvotomy in patients with congenital valvular aortic stenosis.
  • To compare results between infants and older children/adolescents undergoing the procedure.

Main Methods:

  • A retrospective analysis of 22 patients surgically treated for congenital valvular aortic stenosis between 1967 and 1975.
  • Patients were divided into two groups: infants (<1 year) and older individuals (2-24 years).
  • Surgical techniques included cardiopulmonary bypass and deep hypothermia with circulatory arrest.

Main Results:

  • Hospital mortality was 14% in infants, primarily those with associated anomalies.
  • Significant reduction in the left ventricular-aortic systolic pressure gradient was observed postoperatively (86 to 21 mmHg).
  • While results were fair in surviving infants, older patients showed excellent to satisfactory outcomes, with a few experiencing restenosis or mortality.

Conclusions:

  • Aortic valvotomy in infants with congenital aortic stenosis is a palliative measure with considerable risk.
  • The procedure yields more gratifying early and late results in older age groups.
  • Long-term follow-up revealed restenosis as a potential complication requiring reintervention or leading to mortality.

Related Concept Videos

Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...